Zhevavir Entecavir 0.5/1 mg Tablets | Sunrise Remedies
Introduction to Zhevavir Entecavir 0.5/1 mg Tablets
Zhevavir Entecavir 0.5/1 mg Tablets is a pharmaceutical product associated with entecavir, an antiviral medicine used in the management of chronic hepatitis B infection. Understanding a medicine’s active ingredient, strengths, intended use, storage requirements, and prescribing considerations is important for patients, healthcare professionals, pharmaceutical distributors, and other industry stakeholders.
Sunrise Remedies is a pharmaceutical brand that provides product-related information to support awareness of its pharmaceutical portfolio. This article presents general information about Zhevavir Entecavir 0.5/1 mg Tablets, including the role of entecavir, available strengths, responsible medicine use, product handling, and important considerations for pharmaceutical procurement.
Product-specific details, including the marketed formulation, approved indications, packaging, and availability, should always be confirmed through the official product documentation and applicable regulatory information.
What Is Zhevavir Entecavir 0.5/1 mg Tablets?
Zhevavir Entecavir 0.5/1 mg Tablets is identified by its association with entecavir, an antiviral agent primarily used to treat chronic hepatitis B virus (HBV) infection. Hepatitis B is a viral infection that affects the liver and may cause inflammation, liver damage, and long-term complications in some individuals.
Entecavir belongs to a class of medicines known as nucleoside analogue reverse transcriptase inhibitors. It works by interfering with the hepatitis B virus’s ability to reproduce, helping reduce viral replication in the body.
Treatment decisions depend on the patient’s clinical condition, liver health, medical history, laboratory results, and previous antiviral treatment. Entecavir should be used only under the supervision of a qualified healthcare professional.
The Zhevavir brand name and its specific product characteristics should be verified against the relevant product label before purchase, distribution, or clinical use.
Understanding Entecavir 0.5 mg and 1 mg Strengths
Entecavir is available in different strengths, including 0.5 mg and 1 mg tablets in appropriate markets. The prescribed strength depends on the patient’s medical circumstances and treatment history.
Entecavir 0.5 mg: This strength may be prescribed for eligible patients with chronic hepatitis B who meet the relevant clinical criteria. The choice of treatment depends on factors such as previous antiviral exposure and the patient’s overall condition.
Entecavir 1 mg: The higher strength may be recommended in particular clinical circumstances, including certain cases involving previous lamivudine treatment or resistance, depending on the applicable prescribing guidance.
These strengths are not interchangeable on the basis of personal preference. Patients should not change their dosage or switch strengths without consulting their healthcare provider. The appropriate dose may also require adjustment for individuals with impaired kidney function.
For pharmaceutical buyers, healthcare institutions, and distributors, confirming the exact strength, dosage form, approved product details, and pack information is essential before placing an order.
What Is Entecavir Used For?
Entecavir is an antiviral medicine used for the treatment of chronic hepatitis B infection in eligible patients. The infection can persist for years and may require long-term monitoring and medical management.
The medicine helps suppress HBV replication, which may improve certain indicators of liver health and reduce the risk of disease progression in appropriate patients. However, treatment response varies, and entecavir does not guarantee the complete elimination of hepatitis B virus from the body.
People receiving treatment may require regular assessments, including liver function tests and measurements of HBV-related laboratory markers. Their healthcare providers determine how frequently these tests are needed.
It is also important to understand that entecavir is not a general treatment for every type of viral infection. It is intended for specific clinical indications, as described in its approved prescribing information.
How Does Entecavir Work?
Hepatitis B virus uses a complex replication process to produce new viral particles. Entecavir interferes with an important stage of this process by inhibiting the viral polymerase, an enzyme involved in viral DNA synthesis.
By reducing the virus’s ability to replicate, entecavir can lower HBV levels in the bloodstream in appropriately treated patients. This suppression may help manage the infection and support the protection of liver health over time.
The medicine does not replace medical monitoring, and its effects depend on factors such as adherence to the prescribed regimen, the virus’s response to treatment, and the patient’s health status.
Patients should take the medicine exactly as directed and should not discontinue it without medical advice. Stopping hepatitis B treatment can sometimes cause a flare-up of the infection, potentially resulting in serious liver complications.
Important Safety Information and Precautions
Before starting Zhevavir Entecavir 0.5/1 mg Tablets, patients should discuss their medical history and current medicines with a qualified healthcare professional.
Important considerations include:
Kidney function: Entecavir is eliminated mainly through the kidneys. Patients with impaired kidney function may require dosage adjustment.
Previous antiviral treatment: Previous treatment with medicines such as lamivudine can affect the choice of entecavir strength and treatment approach.
HIV infection: People living with HIV and hepatitis B should receive an appropriate treatment plan that addresses both infections. Entecavir should not be used as a substitute for a fully suppressive HIV treatment regimen.
Pregnancy and breastfeeding: Patients should discuss potential benefits and risks with their healthcare provider before using the medicine.
Other medicines: Patients should disclose all prescription medicines, non-prescription products, and supplements they use.
Treatment discontinuation: Stopping therapy may lead to worsening hepatitis B. Any treatment change should be medically supervised.
Possible adverse effects may include headache, fatigue, dizziness, nausea, or other symptoms. Serious complications are possible in some circumstances. Patients experiencing severe or unusual symptoms should seek prompt medical attention.
This information is educational and does not replace the approved product leaflet or individualized medical advice.
Quality, Packaging, and Product Information
Reliable pharmaceutical product information is important for maintaining appropriate handling practices and supporting the responsible distribution of medicines.
When evaluating Zhevavir Entecavir 0.5/1 mg Tablets, buyers and healthcare organizations should verify the following details:
Product identity: Confirm the brand name, active ingredient, strength, dosage form, and applicable registration details.
Packaging information: Review the pack configuration, batch number, manufacturing date, expiry date, and storage instructions provided on the approved packaging.
Documentation: Obtain applicable product specifications, certificates, and regulatory documents through authorized channels where required.
Storage and transportation: Follow the conditions stated on the product label. Medicines should be protected from unsuitable environmental conditions and kept in their original packaging where appropriate.
Traceability: Purchase through authorized and verifiable pharmaceutical supply channels to support product authenticity and distribution accountability.
These checks help pharmaceutical purchasers assess whether a product meets their documentation, handling, and procurement requirements. Specific quality certifications, manufacturing arrangements, and packaging features should be confirmed directly rather than assumed.
Considerations for Pharmaceutical Buyers and Distributors
Pharmaceutical procurement requires careful evaluation of product identity, supplier credentials, regulatory compliance, and supply arrangements. Buyers interested in Zhevavir Entecavir 0.5/1 mg Tablets should review several factors before proceeding.
First, confirm that the required strength is available and that the product’s approved documentation matches the intended market. The regulatory requirements for pharmaceutical products can differ between countries and regions.
Second, assess supplier reliability and the availability of appropriate product documentation. Procurement teams may need information concerning batch traceability, expiry periods, transport conditions, and applicable quality procedures.
Third, clarify commercial requirements such as order quantities, packaging configurations, delivery arrangements, and lead times. These details should be confirmed directly with the relevant supplier because availability and terms may change.
Finally, buyers should ensure that the procurement and distribution of prescription medicines comply with applicable laws and licensing requirements. Products containing entecavir should be supplied and used according to local regulations and approved medical indications.
Why Accurate Information Matters for Entecavir Products
Accurate product information supports responsible medicine use and informed pharmaceutical procurement. Understanding the active ingredient, available strengths, precautions, and approved indications helps patients and healthcare professionals make better-informed decisions.
For distributors and institutional buyers, verifying the product label, regulatory status, documentation, and supply conditions is equally important. These steps help reduce the risk of ordering an incorrect strength or handling a pharmaceutical product outside its specified requirements.
When reviewing Zhevavir Entecavir 0.5/1 mg Tablets, all product-specific statements should be checked against current official documentation. This is particularly important when the information will be used for purchasing, distribution, prescribing, or publication.
Conclusion
Zhevavir Entecavir 0.5/1 mg Tablets is a product associated with entecavir, an antiviral medicine used in the management of chronic hepatitis B infection. Entecavir works by suppressing viral replication, while the appropriate strength and treatment plan depend on individual clinical circumstances and professional medical assessment.
Patients should follow their healthcare provider’s instructions and avoid changing or discontinuing treatment independently. Pharmaceutical buyers and distributors should verify product specifications, regulatory documentation, packaging, and supply details before proceeding with procurement.
For further information regarding Zhevavir Entecavir 0.5/1 mg Tablets and relevant pharmaceutical product inquiries, contact
Sunrise Remedies
Contact Number: +91 7575043215
Email ID: info@sunriseremedies.in
Comments